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life in atopic dermatitis (AD) and a generic quality of life measure
and from this use optimised algorithms to estimate health utility.
METHODS: Multinomial logistic regression was used to esti-
mate response probabilities to the SF-12 health survey from
responses to the Dermatology Life Quality Index (DLQI) in
patients enrolled into a clinical trial studying the long-term use
of tacrolimus ointment. A random sample of 70% of patient
responses was used for the regression analysis, with the remain-
ing 30% used to test the predictive ability of the response
mapping. Predicted and actual SF-12 responses were converted
to SF-6D and EQ-5D health utilities using published algorithms
(Brazier 2004 and Gray 2006) by Monte Carlo simulation.
RESULTS: Evaluable data were available for 255 patients, 40%
of whom were male, and for which the median age at screening
was 28 years (IQR 22 to 38). The percentage of variance in item
response attributable to predictor variable change ranged 15.6%
(SFCALM) to 33.3% (SFLESS). The mean predicted utility in the
test dataset was 0.797 (sd 0.092) by the SF-6D method and 0.787
(0.210) by EQ-5D. The mean squared error (MSE) between the
actual and predicted utilities were 0.013 for SF-6D and 0.068 for
EQ-5D. Predicted SF-6D utility was within 10% of the actual
utility in 62.7% of cases while for predicted EQ-5D utility this
fell to 39.8%. CONCLUSION: Response mapping of disease-
speciﬁc quality of life in AD to generic quality of life SF-12
produced more reliable estimates of SF-6D utility than EQ-5D
utility, and correlated closely with similar estimates made from a
standard assessment of disease severity in eczema.
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OBJECTIVE: To develop a patient self-administered question-
naire assessing the added value of complete independence from
glasses in patients after multifocal intraocular lens surgery.
METHODS: A qualitative study was performed to develop the
questionnaire. Exploratory interviews with ﬁve cataract patients
and six presbyopia patients with ReSTOR® implanted in both
eyes for at least 6 months were conducted. After interview analy-
sis, a conceptual model was developed. Items were generated
simultaneously in French and Spanish based on the identiﬁed
concepts and using patients’ own words. Six patients completed
the French test questionnaire and provided comments regarding
questionnaire’s structure and content. The questionnaire was
reﬁned. The Spanish test questionnaire then underwent a clini-
cian review and was tested with four patients. Test versions were
reﬁned and the French and Spanish pilot versions of the ques-
tionnaire were subsequently produced. RESULTS: Nine global
concepts were included in the conceptual model: global vision,
practical constraints related to wearing glasses, impact of eye
surgery on patient’s life, improvement of the practical issues
without glasses, improvement of the psychological constraints
without glasses, physical appearance / aesthetic aspect (self-
image and in the eyes of the others), surgery left behind, recom-
mendation of surgery to others. The ﬁrst version of the test
questionnaire contained 26 items. After the test with French
patients, two items were deleted. The Spanish test questionnaire
was modiﬁed accordingly. Minor additional changes were
brought after clinician review and patient tests of the Spanish
version. The ﬁnal questionnaire named ‘Freedom from Glasses
Value Scale (FGVS©)’ contained 21 items and four general addi-
tional questions. CONCLUSION: Beyond functional aspects,
this qualitative study identiﬁed additional beneﬁts in cataract
and presbyopic patients’ living free of glasses after receiving
ReSTOR®. The FGVS© will allow these beneﬁts to be assessed.
It is available in French and Spanish. UK English and Danish
linguistically validated versions are also available.
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OBJECTIVE: The purpose of this study was to conduct a
statistical mapping between standard assessments of disease
severity in atopic dermatitis (AD) and a generic quality of life
measure and use optimised algorithms to estimate health utility.
METHODS: Multinomial logistic regression was used to esti-
mate response probabilities to the SF-12 health survey from
assessment of AD severity using the modiﬁed Eczema Area &
Severity Index (mEASI) in patients enrolled into a clinical trial
studying the long-term use of tacrolimus ointment. A random
sample of 70% of patient responses was used for the regression
analysis, with the remaining 30% used to test the predictive
ability of the response mapping. Predicted and actual SF-12
responses were converted to SF-6D and EQ-5D health utilities
using published algorithms (Brazier 2004 and Gray 2006) by
Monte Carlo simulation. RESULTS: Evaluable data were avail-
able for 255 patients, 40% of whom were male, and for which
the median age at screening was 28 years (IQR 22 to 38). The
percentage of variance in item response attributable to predictor
variable change ranged from 19.8% (SFCALM) to 37.5%
(SFENER). The mean predicted utility in the test dataset was
0.799 (sd 0.083) by the SF-6D method and 0.778 (0.203) by
EQ-5D. The mean squared error (MSE) between the actual and
predicted utilities were 0.012 for SF-6D and 0.075 for EQ-5D.
Predicted SF-6D utility was within 10% of the actual utility in
64.8% of cases while for predicted EQ-5D utility this fell to
39.9%. CONCLUSION: In this study response mapping of AD
symptom severity to SF-12 produced more reliable estimates of
SF-6D utility than EQ-5D utility. In young adults with low
co-morbidity the sensitivity of SF-6D at higher utilities make it
be a more appropriate choice than EQ-5D where cases would
otherwise be classiﬁed in perfect health.
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OBJECTIVE: The measurement of oral health related QoL
(OHRQoL) is generally limited to dental diseases. Our objective
was to evaluate patients with oral mucosal diseases using an oral
health-speciﬁc questionnaire (OHIP-14), a generic health status
questionnaire (SF-12) and a general psychological health ques-
tionnaire (GHQ-12) to identify the possible presence of condi-
tions such as depression or anxiety. METHODS: Consecutive
patients coming to the oral health care unit of IDI-IRCCS in
Rome were asked to complete the OHIP-14, the SF-12, and the
GHQ-12 questionnaires. Both physicians and patients gave a
global assessment of severity of disease (PhGA and PtGA, respec-
tively) on a 5-point scale. Agreement between physiscians and
patients was assessed using Cohen’s K statistic. RESULTS: Of
218 patients contacted, 206 participated in the study. Oral ulcer-
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